FzioMed Inc.
This article was originally published in Start Up
Executive Summary
For several years, a handful of manufacturers has been selling biocompatible adhesion barriers aimed to separate tissues from each other during healing so that post-operative adhesions don't form between adjacent structures. FzioMed hopes to offer a cost-effective alternative to this market with a bioresorbable polymer called {Oxiplex}.